(Q34074753)

30 July 2017

1 reference

title

Allergen immunotherapy: current and new therapeutic strategies (English)

1 reference

30 July 2017

1 reference

Rolland JM

1

1 reference

30 July 2017

Douglass J

series ordinal

2

1 reference

30 July 2017

O'Hehir RE

series ordinal

3

1 reference

30 July 2017

language of work or name

English

0 references

publication date

1 March 2000

1 reference

Expert Opinion on Investigational Drugs

30 July 2017

published in

1 reference

30 July 2017

volume

9

1 reference

30 July 2017

issue

3

1 reference

30 July 2017

page(s)

515-527

1 reference

Injection immunotherapy. British Society for Allergy and Clinical Immunology Working Party

30 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1517%2F13543784.9.3.515

Long-term clinical efficacy of grass-pollen immunotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.9.3.515

A double-blind, placebo-controlled trial by the sublingual route of immunotherapy with a standardized grass pollen extract

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.9.3.515

Sublingual-swallow immunotherapy (SLIT) in patients with asthma due to house-dust mites: a double-blind, placebo-controlled study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.9.3.515

Usefulness of immunotherapy in patients with severe summer hay fever uncontrolled by antiallergic drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.9.3.515

Treatment of peanut allergy with rush immunotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.9.3.515

The IgE and IgG subclass antibody response in patients allergic to yellow jacket venom undergoing different regimens of venom immunotherapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.9.3.515

Predictive value of venom-specific IgE, IgG and IgG subclass antibodies in patients on immunotherapy with honey bee venom.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.9.3.515

The Specificity and Regulation of T-Cell Responsiveness to Allergens

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.9.3.515

Lymphokine production by human T cells in disease states

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.9.3.515

Epitope-specific T cell tolerance to phospholipase A2 in bee venom immunotherapy and recovery by IL-2 and IL-15 in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.9.3.515

Differential regulation of T helper phenotype development by interleukins 4 and 10 in an alpha beta T-cell-receptor transgenic system

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.9.3.515

Peripheral deletion of antigen-reactive T cells in oral tolerance.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.9.3.515

Role of interleukin 10 in specific immunotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.9.3.515

Insect venom immunotherapy induces interleukin-10 production and a Th2-to-Th1 shift, and changes surface marker expression in venom-allergic subjects.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.9.3.515

How MHC class II molecules acquire peptide cargo: biosynthesis and trafficking through the endocytic pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.9.3.515

House dust mite allergen characterisation: implications for T-cell responses and immunotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.9.3.515

House dust mite allergy: from T-cell epitopes to immunotherapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.9.3.515

Inhibition of T cell and antibody responses to house dust mite allergen by inhalation of the dominant T cell epitope in naive and sensitized mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.9.3.515

Modulation of the allergic immune response in BALB/c mice by subcutaneous injection of high doses of the dominant T cell epitope from the major birch pollen allergen Bet v 1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.9.3.515

Successful immunotherapy with T-cell epitope peptides of bee venom phospholipase A2 induces specific T-cell anergy in patients allergic to bee venom

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.9.3.515

Studies on allergoids from naturally occurring allergens III. Preparation of ragweed pollen allergoids by aldehyde modification in two steps

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.9.3.515

Dissection of immunoglobulin E and T lymphocyte reactivity of isoforms of the major birch pollen allergen Bet v 1: potential use of hypoallergenic isoforms for immunotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.9.3.515

Recombinant allergens for immunotherapy: a Der p 2 variant with reduced IgE reactivity retains T-cell epitopes

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.9.3.515

Contribution of disulphide bonds to antigenicity of Lep d 2, the major allergen of the dust mite Lepidoglyphus destructor.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.9.3.515

Engineering of hypoallergenic mutants of the Brassica pollen allergen, Bra r 1, for immunotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.9.3.515

Differential regulation of human T cell cytokine patterns and IgE and IgG4 responses by conformational antigen variants.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.9.3.515

Identification, cloning, and sequence of a major allergen (Hev b 5) from natural rubber latex (Hevea brasiliensis).

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.9.3.515

Epitope specificity of the major peanut allergen, Ara h II.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.9.3.515

DNA-Based immunization for asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.9.3.515

Immunotherapy of allergy: anergy, deletion, and immune deviation

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.9.3.515

PROPHYLACTIC INOCULATION AGAINST HAY FEVER

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.9.3.515

21 January 2018

Identifiers

DOI

10.1517/13543784.9.3.515

1 reference

30 July 2017

1 reference